LCS COMPLETE 1294-09-440Recalls & reported problems
Depuy (Ireland) · LCS COMPLETE Low Profile Poly Patella STD · Class 3 · Implant
All models of LCS COMPLETE (18)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10603295022503), received between Apr 15, 2021 and Jun 27, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Naturally Worn” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Naturally Worn1
Patient problems
- Adhesion(s)1
- Cyst(s)1
- Foreign Body Reaction1
- Inflammation1
- Pain1
- Synovitis1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 27, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDICAL RECORDS AD (B)(6) 2023, WERE REVIEWED BY A CLINICIAN. PATIENT UNDERWENT A LEFT TOTAL KNEE ARTHROPLASTY UTILIZING DEPUY SYNTHES IMPLANTS ON (B)(6) 2013 INCLUDING PATELLA. COMPETITOR CEMENT WAS UTILIZED. ON (B)(6) 2023, THE PATIENT UNDERWENT A LEFT TOTAL KNEE REVISION FOR LOOSENING. DARK STAINING OF THE SYNOVIUM WAS PRESENT WITH EXTENSIVE METALLOSIS. THE FEMORAL COMPONENT WAS LOOSE WITH NO INTERFACE CLEARLY PROVIDED. THE TIBIAL COMPONENT WAS ALSO LOOSE AT THE IMPLANT TO CEMENT INTERFACE. THE PATELLA WAS UNDERSIZED ACCORDING TO THE SURGEON AND WAS REVISED. DOI: (B)(6) 2013. DOR: (B)(6) 2023. LEFT KNEE.
Patient problems: Foreign Body Reaction; Synovitis
MAUDE report 17208738 ↗InjuryApr 15, 2021Naturally Worn; Naturally Worn
SUBJECT ID: (B)(6), STUDY: (B)(6). CLINICAL ADVERSE EVENT RECEIVED FOR REVISION OF LEFT PATELLOFEMORAL ARTHROPLASTY TO ADDRESS PROGRESSIVE ARTHRITIS AND POLYETHYLENE BEARING WEAR OF PATELLA COMPONENT. DATE OF IMPLANTATION: (B)(6) 2005. DATE OF REVISION: (B)(6) 2021; (LEFT KNEE). TREATMENT: PATELLOFEMORAL ARTHROPLASTY FEMUR AND PATELLA COMPONENTS REVISED.
Patient problems: Adhesion(s); Cyst(s); Inflammation; Pain
MAUDE report 11671389 ↗
Other Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing devices
- ATTUNE 1506-10-005Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing442 reports
- ATTUNE 1506-10-004Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing442 reports
- ATTUNE 1518-20-038Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing3 deaths393 reports
- LCS SIGMA 1294-33-130Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing1 recall310 reports
- ATTUNE 1518-20-035Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing342 reports
- P.F.C. SIGMA 96-0102Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing1 death319 reports
- ATTUNE 1518-20-041Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing308 reports
- ATTUNE 1506-10-007Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing284 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page